Aruba Science Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.

Press releases published on June 1, 2026

2 hours ago

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis

Indeterminate GlobeNewswire

2 hours ago

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

2 hours ago

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

2 hours ago

Vertex to Present at the 46th Annual William Blair Growth Stock Conference

Indeterminate GlobeNewswire

2 hours ago

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

Indeterminate GlobeNewswire

2 hours ago

Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma

Indeterminate GlobeNewswire

2 hours ago

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

Indeterminate GlobeNewswire

2 hours ago

GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives

Indeterminate GlobeNewswire

2 hours ago

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Indeterminate GlobeNewswire

2 hours ago

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

2 hours ago

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

Indeterminate GlobeNewswire

2 hours ago

Outdoor Holding Company Appoints Director of AI Strategy & Implementation

Indeterminate GlobeNewswire

2 hours ago

Kaltura Named an Exemplary Provider in ISG Research Buyers Guide on Conversational AI

Indeterminate GlobeNewswire

2 hours ago

Floating Fleet AI Showcases AI-Powered Aviation Scheduling Platform at Aviation Festival Americas 2026

Indeterminate GlobeNewswire

2 hours ago

7AI Launches Threat Hunt, Threat Intel Hunt, and Skills, Giving Security Teams the Power to Make AI Agents Work Their Way

Indeterminate GlobeNewswire

2 hours ago

zSpace Eliminates Over $12 Million in Debt Through Conversion to Equity

Indeterminate GlobeNewswire